Episode Details

Daniel Griffin provides a clinical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, reducing viral transmission, and much more, including listener email.

Hosts: Vincent Racaniello,Dickson Despommier, Alan Dove, Rich Condit, Kathy Spindler and Brianne Barker

Guests: Daniel Griffin and Chuck Knirsch

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Safety of Ad5 vectored COVID-19 vaccine (Lancet)
• Analysis of hydroxychloroquine use (Lancet)
• Remdesivir study (NEJM)
• Ancient COVID-19 history (MMWR)
• Drug repurposing for COVID-19 (bioRxiv)
• Why do few COVID-19 patients infect others? (Science)
• Overdispersion in COVID-19 transmission (Wellcome Open Res)
• Reducing airborne transmission (Science)
• Letters read on TWiV 621
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees.

Send your virology questions and comments to twiv@microbe.tv